investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
Catherine Ju-Ying Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Catherine Ju-Ying Wu
Dana-Farber Cancer Institute
Boston, United States
Related projects
Gerd P Pfeifer
5-hydroxymethylcytosine in Human Cancer
Leukaemia
Peter Aplan
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
Leukaemia
Hematology and hematologic malignancies
Alan Rein
Interactions of APOBEC3 Proteins with Murine Leukemia Viruses
Leukaemia
Pathology
Hematology and hematologic malignancies
Ross L Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
Leukaemia
Ya-Huei Kuo
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
Leukaemia
Pathology
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Katy Rezvani
Curative Cell-based Therapies for Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Christophe P Nicot
HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB
Leukaemia
Pathology
Hematology and hematologic malignancies
David A Williams
Rac proteins in hematopoietic cell survival and function
Leukaemia
Hematology and hematologic malignancies